Literature DB >> 11419836

Cross-cultural variation in disease-related concerns among patients with inflammatory bowel disease.

S Levenstein1, Z Li, S Almer, A Barbosa, P Marquis, G Moser, A Sperber, B Toner, D A Drossman.   

Abstract

OBJECTIVE: The aim of this work was to study cross-cultural variations in the impact of inflammatory bowel disease (IBD) on health-related quality of life by an international comparison of disease-related concerns.
METHODS: Item and factor scores on the Rating Form of Inflammatory Bowel Disease Patient Concerns and overall mean concern levels were compared by analysis of variance among 2002 IBD patients in eight countries.
RESULTS: The overall level of concern varied from 51 out of 100 in Portugal to 19 in Sweden, with intermediate scores for Italy (43), Canada (40), United States (39), France (39), Austria (33), and Israel (25). Having surgery, an ostomy, the uncertain nature of the disease, and medication side effects were each rated among the first five in importance in six countries. Other items varied considerably. For example, concern regarding pain and suffering was high in Israel and low in Portugal, whereas concern over developing cancer was low in Italy. Concern over financial issues and access to high-quality health care were inversely associated with measures of national economic prosperity.
CONCLUSIONS: 1) Cross-cultural comparisons of patient concerns related to IBD are feasible using translated scales. 2) Reporting tendencies vary greatly; within Europe, patients from southern countries report greater overall concern. 3) The complications and the variable evolution of disease elicit general concern, but the importance of specific issues varies among countries. 4) The reasons for national differences may have social, cultural, and/or economic determinants with relevance to the patient-physician relationship, patient education, and therapeutic decision making.

Entities:  

Mesh:

Year:  2001        PMID: 11419836     DOI: 10.1111/j.1572-0241.2001.03878.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  34 in total

1.  Patient preferences for first-line oral treatment for mild-to-moderate ulcerative colitis: a discrete-choice experiment.

Authors:  Paul Hodgkins; Paul Swinburn; Dory Solomon; Linnette Yen; Sarah Dewilde; Andrew Lloyd
Journal:  Patient       Date:  2012       Impact factor: 3.883

Review 2.  Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence.

Authors:  J G Williams; S E Roberts; M F Ali; W Y Cheung; D R Cohen; G Demery; A Edwards; M Greer; M D Hellier; H A Hutchings; B Ip; M F Longo; I T Russell; H A Snooks; J C Williams
Journal:  Gut       Date:  2007-02       Impact factor: 23.059

Review 3.  The psyche and the gut.

Authors:  Paul Enck; Ute Martens; Sibylle Klosterhalfen
Journal:  World J Gastroenterol       Date:  2007-07-07       Impact factor: 5.742

4.  Coping strategy when patients with quiescent Crohn's disease recognize that their conditions are worsening.

Authors:  Makoto Tanaka; Yasushi Iwao; Susumu Okamoto; Haruhiko Ogata; Toshifumi Hibi; Keiko Kazuma
Journal:  J Gastroenterol       Date:  2009-07-16       Impact factor: 7.527

5.  Esophageal cancer patients' information management: cross-cultural differences between Dutch and Italian patients in perceived quality of provided oncological information.

Authors:  Luca M Saadeh; Annelijn E Slaman; Eleonora Pinto; Suzanne S Gisbertz; Francesco Cavallin; Egle Jezerskyte; Rita Alfieri; Loes Noteboom; Maria Cristina Bellissimo; Matteo Cagol; Giovanni Pirozzolo; Carlo Castoro; Marco Scarpa; Mark I van Berge Henegouwen
Journal:  J Thorac Dis       Date:  2018-08       Impact factor: 2.895

6.  Predictors of abdominal pain in depressed pediatric inflammatory bowel disease patients.

Authors:  Arvind I Srinath; Alka Goyal; Lori A Zimmerman; Melissa C Newara; Margaret A Kirshner; Francis Nicole McCarthy; David Keljo; David Binion; Athos Bousvaros; David R DeMaso; Ada Youk; Eva M Szigethy
Journal:  Inflamm Bowel Dis       Date:  2014-08       Impact factor: 5.325

Review 7.  Systematic review of health-related quality of life after esophagectomy for esophageal cancer.

Authors:  Marco Scarpa; Stefano Valente; Rita Alfieri; Matteo Cagol; Giorgio Diamantis; Ermanno Ancona; Carlo Castoro
Journal:  World J Gastroenterol       Date:  2011-11-14       Impact factor: 5.742

8.  Health-related quality of life in patients with oesophageal cancer: analysis at different steps of the treatment pathway.

Authors:  Marco Scarpa; Luca M Saadeh; Alessandra Fasolo; Rita Alfieri; Matteo Cagol; Francesco Cavallin; Eleonora Pinto; Giovanni Zaninotto; Ermanno Ancona; Carlo Castoro
Journal:  J Gastrointest Surg       Date:  2013-01-08       Impact factor: 3.452

9.  Impact of perceived stigma on inflammatory bowel disease patient outcomes.

Authors:  Tiffany H Taft; Laurie Keefer; Christoph Leonhard; Michele Nealon-Woods
Journal:  Inflamm Bowel Dis       Date:  2009-08       Impact factor: 5.325

10.  The impact of ulcerative colitis is greater in unmarried and young patients.

Authors:  R G Maunder; G R Greenberg; W J Lancee; A Hillary Steinhart; M S Silverberg
Journal:  Can J Gastroenterol       Date:  2007-11       Impact factor: 3.522

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.